Psychostimulants Increase Effort but Reduce Effectiveness in Cognitive Tasks
Psychostimulants like methylphenidate, modafinil, and dextroamphetamine increase catecholamine levels—dopamine, adrenaline, and noradrenaline. This leads to hyperfocus and a sense of flow, but does not improve intelligence or thinking quality. A clinical study on humans showed that such substances increase the number of cognitive iterations but reduce the value of each step. The quantity of effort rises, while quality declines.
Nootropics stimulate neurogenesis and memory formation through the hippocampus, affecting memory and comprehension. Stimulants, on the other hand, are geared toward concentration for tasks like "grinding through a project to completion." In the U.S., they are often called "study drugs," but the effect is illusory.
Research Methodology: The Knapsack Problem
Participants were divided into four groups: three with drugs (methylphenidate, modafinil, dextroamphetamine) and one with a placebo. The task was to optimize a virtual knapsack of limited volume, maximizing the value of items within 4 minutes. This is an NP-hard problem, similar to inventory management in games like Diablo or Skyrim.
The hypothesis was that increased catecholamines would boost motivation, effort, and performance. The following were evaluated:
- Probability of finding the optimal solution.
- Total value of the knapsack.
- Time spent on the task.
- Number of item moves (cognitive iterations).
- Productivity per move (value gain per iteration).
Tasks varied in difficulty on the Sahni-k scale.
Results: More Hustle, Less Benefit
Probability of Success
A statistical model accounted for difficulty, participant parameters, and drug factors. The result: drugs do not affect the chance of finding the correct solution. Neither guessing nor exhaustive search improved.
Solution Value
The average knapsack value under stimulants was lower than with the placebo. The probability of "sloppy work" (low-value sets) was higher at all difficulty levels. Distribution graphs confirm: solutions were worse.
Time and Iterations
Participants on drugs spent more time. On easy tasks—as much as the placebo group on difficult ones. The number of item moves increased: more iterations, but speed (seconds/move) was ambiguous.
Motivation, as time + steps, increases, but speed and quality do not. From the outside, it looks like hustle without payoff.
Effort Quality
Move productivity—the average value gain relative to the maximum—was lower for all three drugs compared to placebo. The reduction is equivalent to increasing task difficulty by 1.5 units on the Sahni-k scale.
Effect Comparison in Table
| Parameter | Placebo | Stimulants |
|---------------------------|-----------------|-----------------|
| Probability of success | Baseline | No change |
| Average knapsack value | Higher | Lower |
| Time on task | Less | More |
| Number of iterations | Less | More |
| Move productivity | Higher | Lower (~1.5 Sahni-k) |
When Stimulants Are Useful
Drugs are effective in routine tasks: repetitive actions, ample time resources, boring iterations like "dig until lunch." For intellectual work—understanding the big picture, connecting past experience with future goals—they are useless. There is no boost in strategic thinking.
Key Takeaways
- Stimulants increase the number of iterations but reduce the quality of each step in complex tasks.
- No effect on success probability: drugs do not help find the optimal solution.
- Time increases: easy tasks take as long as difficult ones without drugs.
- Illusion of productivity: more effort creates the appearance of busyness without real progress.
- Recommendation: for memory and learning—neurogenesis (rest, nutrition), not stimulants.
— Editorial Team
No comments yet.